Shared on19 Aug 25Fair value Decreased 40%
Flora Growth’s consensus Analyst Price Target was notably reduced from $156.00 to $93.00 due to continued gross margin pressure, underwhelming operational progress despite a strategic shift toward branded U.S. and European opportunities, and softer-than-expected recent results, although long-term confidence in management’s direction remains. Analyst Commentary Gross margin pressure negatively impacted Flora Growth's bottom line results this quarter.
Shared on04 Aug 25Fair value Increased 6k%
The consensus analyst price target for Flora Growth has surged—primarily reflecting an elimination of earnings valuation multiples and an improved revenue growth outlook—raising the fair value estimate from $2.75 to $156.00. What's in the News Announced a 1-for-39 reverse stock split effective August 2025.
Shared on24 Apr 25Fair value Increased 8.36%
AnalystConsensusTarget has decreased revenue growth from 7.2% to 4.0%, decreased profit margin from 5.6% to 5.0%, increased future PE multiple from 25.4x to 34.2x and decreased shares outstanding growth rate from 0.3% to 0.1%.